These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24909578)

  • 1. Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.
    Tan KR; Katalenich BL; Mace KE; Nambozi M; Taylor SM; Meshnick SR; Wiegand RE; Chalwe V; Filler SJ; Kamuliwo M; Craig AS
    Malar J; 2014 Jun; 13():227. PubMed ID: 24909578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
    Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R
    Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
    Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
    Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi.
    Gutman J; Mwandama D; Wiegand RE; Abdallah J; Iriemenam NC; Shi YP; Mathanga DP; Skarbinski J
    Malar J; 2015 May; 14():197. PubMed ID: 25962439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo.
    Kayiba NK; Yobi DM; Tchakounang VRK; Mvumbi DM; Kabututu PZ; Devleesschauwer B; Mukomena ES; DeMol P; Hayette MP; Mvumbi GL; Rosas-Aguirre A; Lusamba PD; Speybroeck N
    Infect Genet Evol; 2021 Oct; 94():105009. PubMed ID: 34284138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
    Dosoo DK; Bailey JA; Asante KP; Oppong FB; Niaré K; Opoku-Mensah J; Owusu-Agyei S; Greenwood B; Chandramohan D
    PLoS One; 2022; 17(8):e0271489. PubMed ID: 35939419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria.
    Fagbemi KA; Adebusuyi SA; Nderu D; Adedokun SA; Pallerla SR; Amoo AOJ; Thomas BN; Velavan TP; Ojurongbe O
    Infect Genet Evol; 2020 Nov; 85():104503. PubMed ID: 32805431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
    Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
    Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.
    Siame MN; Mharakurwa S; Chipeta J; Thuma P; Michelo C
    Malar J; 2015 May; 14():190. PubMed ID: 25943379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sulfadoxine-pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation.
    Cohen O; Guemas E; Menard S; Tsague Kenfack M; Talom Ngassa C; Iriart X; Bidzogo Lebobo M; Ondobo Ekae C; Eboumbou C; Tiyou Kenmeni C; Berry A
    J Antimicrob Chemother; 2023 Mar; 78(3):665-668. PubMed ID: 36611259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
    Bwire GM; Mikomangwa WP; Kilonzi M
    BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.
    Warsame M; Hassan AM; Barrette A; Jibril AM; Elmi HH; Arale AM; Mohammady HE; Nada RA; Amran JG; Muse A; Yusuf FE; Omar AS
    Trop Med Int Health; 2015 Apr; 20(4):510-7. PubMed ID: 25583123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine in Parts of Ghana: A Threat to ITPTp-SP?
    Afutu LL; Boampong JN; Quashie NB
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33404643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequencies of dhfr/dhps multiple mutations and Plasmodium falciparum submicroscopic gametocyte carriage in Gabonese pregnant women following IPTp-SP implementation.
    Bouyou-Akotet MK; Tshibola ML; Mawili-Mboumba DP; Nzong J; Bahamontes-Rosa N; Tsoumbou-Bakana G; Kombila M
    Acta Parasitol; 2015 Jun; 60(2):218-25. PubMed ID: 26203988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007-2015): In vivo response and dhfr and dhps mutations.
    Kakar Q; Sheikh S; Ahmed I; Khan MA; Jamil M; ElMohammady H; Warsame M
    Acta Trop; 2016 Dec; 164():17-22. PubMed ID: 27515812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained clinical benefit of malaria chemoprevention with sulfadoxine-pyrimethamine (SP) in pregnant women in a region with high SP resistance markers.
    Matambisso G; Brokhattingen N; Maculuve S; Cístero P; Mbeve H; Escoda A; Bambo G; Cuna B; Melembe C; Ndimande N; Tetteh KKA; Drakeley C; Gamain B; Chitnis C; Chauhan V; Quintó L; Macete E; Mayor A
    J Infect; 2024 May; 88(5):106144. PubMed ID: 38574776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.